|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tan A, Yeh SH, Liu CJ, Cheung C and Chen
PJ: Viral hepatocarcinogenesis: From infection to cancer. Liver
Int. 28:175–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lupberger J and Hildt E: Hepatitis B
virus-induced oncogenesis. World J Gastroenterol. 13:74–81. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marra M, Sordelli IM, Lombardi A, Lamberti
M, Tarantino L, Giudice A, Stiuso P, Abbruzzese A, Sperlongano R,
Accardo M, et al: Molecular targets and oxidative stress biomarkers
in hepatocellular carcinoma: An overview. J Transl Med. 9:1712011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McClain SL, Clippinger AJ, Lizzano R and
Bouchard MJ: Hepatitis B virus replication is associated with an
HBx-dependent mitochondrion-regulated increase in cytosolic calcium
levels. J Virol. 81:12061–12065. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan J, Lian Z, Wallett S and Feitelson MA:
The hepatitis B x antigen effector, URG7, blocks tumour necrosis
factor alpha-mediated apoptosis by activation of phosphoinositol
3-kinase and beta-catenin. J Gen Virol. 88:3275–3285. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang B and Bouchard MJ: The hepatitis B
virus X protein elevates cytosolic calcium signals by modulating
mitochondrial calcium uptake. J Virol. 86:313–327. 2012. View Article : Google Scholar :
|
|
8
|
Yamashita T, Budhu A, Forgues M and Wang
XW: Activation of hepatic stem cell marker EpCAM by
Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res.
67:10831–10839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang W, Lu Z, Kong G, Gao Y, Wang T, Wang
Q, Cai N, Wang H, Liu F, Ye L, et al: Hepatitis B virus X protein
accelerates hepatocarcinogenesis with partner survivin through
modulating miR-520b and HBXIP. Mol Cancer. 13:1282014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bandopadhyay M, Banerjee A, Sarkar N,
Panigrahi R, Datta S, Pal A, Singh SP, Biswas A, Chakrabarti S and
Chakravarty R: Tumor suppressor microRNA miR-145 and onco microRNAs
miR-21 and miR-222 expressions are differentially modulated by
hepatitis B virus X protein in malignant hepatocytes. BMC Cancer.
14:7212014. View Article : Google Scholar
|
|
12
|
Li JF, Dai XP, Zhang W, Sun SH, Zeng Y,
Zhao GY, Kou ZH, Guo Y, Yu H, Du LY, et al: Upregulation of
microRNA-146a by hepatitis B virus X protein contributes to
hepatitis development by downregulating complement factor H. MBio.
6:e02459-e142015. View Article : Google Scholar
|
|
13
|
Damania P, Sen B, Dar SB, Kumar S, Kumari
A, Gupta E, Sarin SK and Venugopal SK: Hepatitis B virus induces
cell proliferation via HBx-induced microRNA-21 in hepatocellular
carcinoma by targeting programmed cell death protein4 (PDCD4) and
phosphatase and tensin homologue (PTEN). PLoS One. 9:e917452014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB
and Chen Y: Hepatitis B virus X protein promotes hepatocellular
carcinoma transformation through interleukin-6 activation of
microRNA-21 expression. Eur J Cancer. 50:2560–2569. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kobayashi M, Fitz L, Ryan M, Hewick RM,
Clark SC, Chan S, Loudon R, Sherman F, Perussia B and Trinchieri G:
Identification and purification of natural killer cell stimulatory
factor (NKSF), a cytokine with multiple biologic effects on human
lymphocytes. J Exp Med. 170:827–845. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stern AS, Podlaski FJ, Hulmes JD, Pan YC,
Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T and
Chizzonite R: Purification to homogeneity and partial
characterization of cytotoxic lymphocyte maturation factor from
human B-lymphoblastoid cells. Proc Natl Acad Sci USA. 87:6808–6812.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang
Y and Wu C: Mycobacterium tuberculosis-specific
IL-21+IFN-γ+CD4+ T cells are
regulated by IL-12. PLoS One. 11:e01473562016. View Article : Google Scholar
|
|
18
|
Otani T, Nakamura S, Toki M, Motoda R,
Kurimoto M and Orita K: Identification of IFN-gamma-producing cells
in IL-12/IL-18-treated mice. Cell Immunol. 198:111–119. 1999.
View Article : Google Scholar
|
|
19
|
Zeh HJ III, Hurd S, Storkus WJ and Lotze
MT: Interleukin-12 promotes the proliferation and cytolytic
maturation of immune effectors: Implications for the immunotherapy
of cancer. J Immunother Emphasis Tumor Immunol. 14:155–161. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuzhalin AE and Kutikhin AG:
Interleukin-12: Clinical usage and molecular markers of cancer
susceptibility. Growth Factors. 30:176–191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lasek W, Zagożdżon R and Jakobisiak M:
Interleukin 12: Still a promising candidate for tumor
immunotherapy? Cancer Immunol Immunother. 63:419–435. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alatrash G, Hutson TE, Molto L, Richmond
A, Nemec C, Mekhail T, Elson P, Tannenbaum C, Olencki T, Finke J,
et al: Clinical and immunologic effects of subcutaneously
administered interleukin-12 and interferon alfa-2b: Phase I trial
of patients with metastatic renal cell carcinoma or malignant
melanoma. J Clin Oncol. 22:2891–2900. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gollob JA, Veenstra KG, Parker RA, Mier
JW, McDermott DF, Clancy D, Tutin L, Koon H and Atkins MB: Phase I
trial of concurrent twice-weekly recombinant human interleukin-12
plus low-dose IL-2 in patients with melanoma or renal cell
carcinoma. J Clin Oncol. 21:2564–2573. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Fu H, Xu C, Tie Y, Xing R, Zhu J,
Qin Y, Sun Z and Zheng X: miR-183 inhibits TGF-beta1-induced
apoptosis by downregulation of PDCD4 expression in human
hepatocellular carcinoma cells. BMC Cancer. 10:354–363. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Motzer RJ and Bukowski RM: Targeted
therapy for metastatic renal cell carcinoma. J Clin Oncol.
24:5601–5608. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cody JJ, Scaturro P, Cantor AB, Yancey
Gillespie G, Parker JN and Markert JM: Preclinical evaluation of
oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12
for therapy of breast cancer brain metastases. Int J Breast Cancer.
2012:6286972012. View Article : Google Scholar
|
|
29
|
Parker JN, Gillespie GY, Love CE, Randall
S, Whitley RJ and Markert JM: Engineered herpes simplex virus
expressing IL-12 in the treatment of experimental murine brain
tumors. Proc Natl Acad Sci USA. 97:2208–2213. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Benhenda S, Cougot D, Buendia MA and
Neuveut C: Hepatitis B virus X protein molecular functions and its
role in virus life cycle and pathogenesis. Adv Cancer Res.
103:75–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kong GY, Zhang JP, Zhang S, Shan CL, Ye LH
and Zhang XD: Hepatitis B virus X protein promotes hepatoma cell
proliferation via upregulation of MEKK2. Acta Pharmacol Sin.
32:1173–1180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xia LM, Huang WJ, Wu JG, Yang YB, Zhang Q,
Zhou ZZ, Zhu HF, Lei P, Shen GX and Tian DA: HBx protein induces
expression of MIG and increases migration of leukocytes through
activation of NF-kappaB. Virology. 385:335–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang WC, Chen WS, Chen YJ, Wang LY, Hsu
SC, Chen CC and Hung MC: Hepatitis B virus X protein induces IKKα
nuclear translocation via Akt-dependent phosphorylation to promote
the motility of hepatocarcinoma cells. J Cell Physiol.
227:1446–1454. 2012. View Article : Google Scholar
|
|
34
|
Gaur AB, Holbeck SL, Colburn NH and Israel
MA: Downregulation of Pdcd4 by mir-21 facilitates glioblastoma
proliferation in vivo. Neuro-oncol. 13:580–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou X, Ren Y, Moore L, Mei M, You Y, Xu
P, Wang B, Wang G, Jia Z, Pu P, et al: Downregulation of miR-21
inhibits EGFR pathway and suppresses the growth of human
glioblastoma cells independent of PTEN status. Lab Invest.
90:144–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
